Key Takeaways
- • Othram acquires Sorenson Forensics as a wholly owned subsidiary, consolidating evidence assessment, biological screening, traditional forensic DNA testing, forensic genomics, and genetic genealogy capabilities under single ownership.
- • Integration enables coordinated testing strategy development at the outset of investigations, optimizing resource allocation when evidence is limited and planning for both immediate and advanced testing methodologies.
- • Sorenson Forensics maintains its Draper, Utah operations, existing team, accreditation, and licensing post-acquisition, reducing integration risk and preserving established client relationships and certifications.
- • Combined entity positions agencies to engage Othram at investigation inception rather than downstream, potentially improving case outcomes for both active investigations and cold cases through early strategic planning.
Summary
Othram announced the acquisition of Sorenson Forensics on September 29, 2026, bringing together complementary forensic investigation capabilities under unified ownership. The acquisition consolidates evidence assessment, biological screening, traditional forensic DNA testing, Othram's proprietary forensic genomics, and genetic genealogy services into a single operational structure, with Sorenson Forensics operating as a wholly owned subsidiary.
The strategic rationale centers on optimizing investigative workflow from case inception. According to David Mittelman, Othram CEO, early decisions about evidence screening and testing methodologies can fundamentally shape investigation outcomes. By integrating Sorenson Forensics' capabilities with Othram's advanced offerings, the combined entity enables agencies to develop coordinated testing strategies at the beginning of an investigation rather than selecting testing approaches reactively. This is particularly material when evidence quantities are constrained, as the unified team can evaluate both immediate DNA analysis needs and longer-term potential for single nucleotide polymorphism (SNP) testing and forensic genetic genealogy applications.
Operationally, Sorenson Forensics will retain its established Draper, Utah location and continue functioning with its existing team structure, accreditation status, and licensing framework. This preservation of operational continuity minimizes disruption to current investigations and reduces integration friction typically associated with forensic laboratory consolidations. The retained expertise in biological screening, traditional forensic DNA analysis, case consultation, and expert testimony expands Othram's service offerings and addresses both active case support and cold case investigation applications.
The acquisition reflects consolidation within the forensic genomics and DNA analysis sector, positioning Othram to serve as a full-service provider capable of guiding law enforcement agencies through the complete forensic testing lifecycle, from initial evidence evaluation through advanced genetic genealogy investigation.
The strategic rationale centers on optimizing investigative workflow from case inception. According to David Mittelman, Othram CEO, early decisions about evidence screening and testing methodologies can fundamentally shape investigation outcomes. By integrating Sorenson Forensics' capabilities with Othram's advanced offerings, the combined entity enables agencies to develop coordinated testing strategies at the beginning of an investigation rather than selecting testing approaches reactively. This is particularly material when evidence quantities are constrained, as the unified team can evaluate both immediate DNA analysis needs and longer-term potential for single nucleotide polymorphism (SNP) testing and forensic genetic genealogy applications.
Operationally, Sorenson Forensics will retain its established Draper, Utah location and continue functioning with its existing team structure, accreditation status, and licensing framework. This preservation of operational continuity minimizes disruption to current investigations and reduces integration friction typically associated with forensic laboratory consolidations. The retained expertise in biological screening, traditional forensic DNA analysis, case consultation, and expert testimony expands Othram's service offerings and addresses both active case support and cold case investigation applications.
The acquisition reflects consolidation within the forensic genomics and DNA analysis sector, positioning Othram to serve as a full-service provider capable of guiding law enforcement agencies through the complete forensic testing lifecycle, from initial evidence evaluation through advanced genetic genealogy investigation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.